Aptorum Group shares surge 64.95% intraday after announcing an all-stock merger with DiamiR Biosciences.
ByAinvest
Wednesday, Jul 16, 2025 9:45 am ET1min read
APM--
Aptorum Group Limited rose 64.95% in intraday trading, following the announcement of a definitive agreement for an all-stock merger transaction with DiamiR Biosciences. The merger will see DiamiR Biosciences become a wholly-owned subsidiary of Aptorum Group, which is expected to enhance the company's capabilities in developing innovative blood-based tests for brain health and other diseases.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet